AI in Healthcare: Ultromics' $55M Boost, MetaVia's Drug Development, and Profluent's Genome Breakthrough - Life AI Weekly #28

Hi there,

In this edition of Life AI Weekly, we're diving into the latest advancements in healthcare and life sciences AI. Ultromics has secured $55 million to enhance heart failure detection, a significant step forward in cardiovascular care. Meanwhile, Human Longevity is expanding its cancer pledge to include lung cancer, aiming to leverage AI for early detection and treatment strategies.

Additionally, MetaVia and Syntekabio are collaborating on AI for the development of DA-1241, a promising new drug. In the realm of healthcare tech, Labcorp has introduced an AI tool designed to optimize lab test selection, potentially improving diagnostic accuracy and efficiency. Stay tuned as we explore these stories and more in the world of AI-driven healthcare innovations.

ARCHIMED has acquired a majority stake in Arkstone to enhance AI-driven clinical decision support. MAGENTIQ EYE LTD. completed a Series A funding round to commercialize its AI software for colonoscopy polyp detection. PAR acquired Assessment Assist AI to integrate AI solutions for mental health professionals. Ultromics raised $55 million to expand its EchoGo® technology for heart failure detection. PhnyX Lab secured $4 million to expand its Cheiron platform. MediSpend acquired Alucio to enhance AI stakeholder engagement solutions. METiS Technologies raised RMB 400 million to boost biopharmaceutical innovation.

Profluent has published research in Nature about OpenCRISPR-1, an AI-generated genome editor for human genome editing. Turbine has announced a collaboration with MSD to develop AI-driven simulations of challenging cancer patient populations. On July 30, 2025, Atombeat and BioDuro announced a strategic collaboration to develop an AI-powered platform to accelerate peptide drug discovery. MetaVia Inc. has partnered with Syntekabio to use AI in exploring new therapeutic applications for DA-1241.

Dr. Peter Derman has joined the advisory board of Metamorphosis to enhance robotic surgery. Human Longevity, Inc. expands its cancer pledge to include lung cancer with AI-driven detection. Apple, Google, and OpenAI partner with US agencies to improve health data sharing. RIVANNA receives $9.92 million from BARDA for AI module development. C8 Health secures $12 million to advance its AI healthcare platform. University of Pennsylvania develops a model predicting CAR T-cell therapy response. Alder Hey NHS Trust unveils an AI strategy for child healthcare.